Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 2144-2151, 2007. First published October 19, 2007; 10.1373/clinchem.2007.090670
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.090670v1
53/12/2144    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinha, M. K.
Right arrow Articles by Mistry, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinha, M. K.
Right arrow Articles by Mistry, J. S.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2007;53:2144-2151.)
© 2007 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

Analytical Validation and Biological Evaluation of a High–Molecular-Weight Adiponectin ELISA

Madhur K. Sinha1,a, Traci Songer1, Qiang Xiao1, John H. Sloan1, Jin Wang1, Shaoquen Ji1, William E. Alborn2, Randy A. Davis2, Michael M. Swarbrick3, Kimber L. Stanhope3, Bruce M. Wolfe4, Peter J. Havel3, Todd Schraw5, Robert J. Konrad2, Philipp E. Scherer5 and Jehangir S. Mistry1

1 Millipore Bioscience Division, Millipore Corporation, St. Charles, MO.
2 Division of Laboratory and Experimental Medicine, Eli-Lilly Company, Indianapolis, IN.
3 Department of Nutrition, University of California, Davis, CA.
4 Division of General Surgery, Oregon Health and Science University, Portland, OR.
5 Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX.

aAddress correspondence to this author at: Millipore Bioscience Division, 6 Research Park Dr., St. Charles, MO 63304. Fax 636-442-6087; e-mail Madhur_Sinha{at}Millipore.com.

Background: Of the 3 circulating multimeric forms of adiponectin, the high–molecular-weight (HMW) form, as measured by size-exclusion and/or immunoblotting techniques, is a better index of insulin sensitivity for monitoring health and disease than is total adiponectin. We aimed to develop a simple ELISA to measure HMW adiponectin.

Methods: We pretreated serum or plasma samples with digestion solution containing proteinase K (Millipore, ESDS). HMW (Millipore, EZHMWA-64K) and total adiponectin (Millipore, EZHADP-61K) concentrations were measured in treated and untreated samples, respectively, from 108 individuals and from 20 morbidly obese patients before and at 1, 3, 6, and 12 months after gastric-bypass surgery.

Results: The ELISA has a dynamic range of 3–200 µg/L and a detection limit of 0.8 µg/L. Intraassay and interassay CVs were <4% and <10%, respectively. Sample-dilution curves paralleled the calibration curves. Fast protein liquid chromatography profiles of the proteinase K-treated samples revealed predominantly HMW adiponectin. Values for HMW adiponectin produced with this method are comparable with those obtained with Western blot analysis (y = 0.77x – 0.15; r = 0.96; n = 56). Body mass index (BMI)- and sex-related changes were more pronounced for HMW adiponectin and percentage of HMW adiponectin than for total adiponectin. HMW and total adiponectin increased after bypass surgery, but changes in HMW adiponectin were more pronounced and preceded changes in total adiponectin.

Conclusion: This simple, rapid ELISA for HMW adiponectin recognizes the HMW isoform, produces results closely correlated with those obtained with Western blotting, and appears to better distinguish BMI-, sex-, and weight loss–associated differences than assays for total adiponectin.




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. M. E. Blumer, S. N. van der Crabben, M. E. Stegenga, M. W. Tanck, M. T. Ackermans, E. Endert, T. van der Poll, and H. P. Sauerwein
Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E613 - E617.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.